These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38012254)

  • 1. Metabolic health status and renal disorders: a cross-sectional study.
    Moeinzadeh F; Rouhani MH; Seirafian S; Vahdat S; Mortazavi M; Clark CCT; Shahdadian F
    Sci Rep; 2023 Nov; 13(1):20794. PubMed ID: 38012254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population.
    Chen HY; Lu FH; Chang CJ; Wang RS; Yang YC; Chang YF; Wu JS
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):418-425. PubMed ID: 31744713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between metabolic phenotype and urinary albumin-creatinine ratio in Chinese community adults: A cross-sectional study.
    Zhang Y; Li B; Liu Y; Gao W; Chen K; Wang A; Tang X; Yan L; Luo Z; Qin G; Chen L; Wan Q; Gao Z; Wang W; Ning G; Mu Y
    J Diabetes; 2022 Aug; 14(8):541-550. PubMed ID: 36040203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of liver cirrhosis based on the metabolic health and weight criteria: Report from the Korea National Health and Nutrition Examination Survey (KNHANES) data analysis.
    Mun H; So ES
    Ann Hepatol; 2023; 28(4):100721. PubMed ID: 35504573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese.
    Wang Y; Sun B; Sheng LT; Pan XF; Zhou Y; Zhu J; Li X; Yang K; Guo K; Zhang X; He M; Yang H; Wu T; Pan A
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2017-2026. PubMed ID: 32826134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: A systematic review and meta-analysis.
    Iqbal J; Wu HX; Nawaz MA; Jiang HL; Xu SN; Huang BL; Li L; Cai JM; Zhou HD
    Obes Rev; 2024 Feb; 25(2):e13656. PubMed ID: 37904643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.
    Jam SA; Moloudpour B; Najafi F; Darbandi M; Pasdar Y
    BMC Nephrol; 2022 Jul; 23(1):233. PubMed ID: 35778682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between different metabolic phenotypes of obesity and thyroid disorders among Chinese adults: a nationwide cross-sectional study.
    Song B; Lu C; Teng D; Shan Z; Teng W
    Front Endocrinol (Lausanne); 2023; 14():1158013. PubMed ID: 37152970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Metabolic Obesity Phenotypes with Cardiometabolic Index, Atherogenic Index of Plasma and Novel Anthropometric Indices: A Link of FTO-rs9939609 Polymorphism.
    Abolnezhadian F; Hosseini SA; Alipour M; Zakerkish M; Cheraghian B; Ghandil P; Cheraghpour M
    Vasc Health Risk Manag; 2020; 16():249-256. PubMed ID: 32612360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study.
    Zakerkish M; Hoseinian A; Alipour M; Payami SP
    BMC Endocr Disord; 2023 May; 23(1):122. PubMed ID: 37246210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis.
    Alizadeh S; Esmaeili H; Alizadeh M; Daneshzad E; Sharifi L; Radfar H; Radaei MK
    Arch Endocrinol Metab; 2019 Jul; 63(4):427-437. PubMed ID: 31365625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of incident obesity phenotype in nonobese healthy adults.
    Eftekharzadeh A; Asghari G; Serahati S; Hosseinpanah F; Azizi A; Barzin M; Mirmiran P; Azizi F
    Eur J Clin Invest; 2017 May; 47(5):357-365. PubMed ID: 28294315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between alternative healthy eating index (AHEI) with metabolic health status in adolescents with overweight and obesity.
    Poursalehi D; Bahrami G; Mirzaei S; Asadi A; Akhlaghi M; Saneei P
    BMC Public Health; 2024 Jan; 24(1):42. PubMed ID: 38166997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population.
    Zheng J; Li X; Zhang Y; Miao Y; Zhang Q
    J Transl Med; 2023 Jan; 21(1):39. PubMed ID: 36681819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between being metabolically healthy/unhealthy and metabolic syndrome in Iranian adults.
    Tabatabaei-Malazy O; Saeedi Moghaddam S; Masinaei M; Rezaei N; Mohammadi Fateh S; Dilmaghani-Marand A; Abdolhamidi E; Razi F; Khashayar P; Mahdavihezaveh A; Mirab Samiee S; Larijani B; Farzadfar F
    PLoS One; 2022; 17(1):e0262246. PubMed ID: 34990491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.